FMF patients routinely presenting to our outpatient clinic are regularly monitored for subclinical disease activity via measurement of classical inflammatory markers (CRP, SAA, and ESR) and additionally with the routinely available marker S100A8/A9. The gene discussed is S100A8; the disease is familial Mediterranean fever.